Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2026-02-25 @ 6:35 PM
Study NCT ID:
NCT01765361
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2012-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-21
First Submit QC Date:
None
Study First Post Date:
2013-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-31
Last Update Post Date:
2017-02-01
Last Update Post Date Type:
ESTIMATED